Apr 9, 09:25 PM

Illumina CFO Goswami Exits, Dhingra from Summit Therapeutics Takes Over

Illumina announced that its Chief Financial Officer, Joydeep Goswami, will depart from the company. He will be succeeded by Ankur Dhingra, who previously served as an executive at Summit Therapeutics. This leadership change, affecting the gene sequencing company, was confirmed by Illumina on Tuesday. The company's stock, $ILMN, may be impacted by this announcement.

#Illumina #Joydeep Goswami #Ankur Dhingra #Summit Therapeutics

Written with ChatGPT (GPT-4).

Sources

Reuters Health@Reuters_Health
2 years ago
Illumina said on Tuesday Chief Financial Officer Joydeep Goswami will leave the gene sequencing company and be succeeded by former Summit Therapeutics' executive Ankur Dhingra. https://t.co/iFDXDvN8bg https://t.co/iFDXDvN8bg
Reuters Health@Reuters_Health
2 years ago
Illumina said on Tuesday Chief Financial Officer Joydeep Goswami will leave the gene sequencing company and be succeeded by former Summit Therapeutics' executive Ankur Dhingra. https://t.co/poRJaFxsvW https://t.co/poRJaFxsvW
Mike@NonGaap
2 years ago
“Illumina said on Tuesday Chief Financial Officer Joydeep Goswami will leave the gene sequencing company and be succeeded by former Summit Therapeutics' executive Ankur Dhingra.” $ILMN https://t.co/5h9eoHboFs

Additional media

Image #1 for story illumina-cfo-goswami-exits-dhingra-summit-therapeutics-takes

Illumina CFO Goswami Exits, Dhingra from Summit Therapeutics Takes Over

Sources

Additional media

Similar Stories